These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
502 related articles for article (PubMed ID: 9714305)
21. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation. Butler AM; Murray M J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313 [TBL] [Abstract][Full Text] [Related]
22. Characterization of the NADPH-dependent metabolism of 17beta-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome P450 3A4 and 3A5. Lee AJ; Kosh JW; Conney AH; Zhu BT J Pharmacol Exp Ther; 2001 Aug; 298(2):420-32. PubMed ID: 11454902 [TBL] [Abstract][Full Text] [Related]
23. Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily. Ono S; Hatanaka T; Miyazawa S; Tsutsui M; Aoyama T; Gonzalez FJ; Satoh T Xenobiotica; 1996 Nov; 26(11):1155-66. PubMed ID: 8948091 [TBL] [Abstract][Full Text] [Related]
24. O-Dealkylation of fluoxetine in relation to CYP2C19 gene dose and involvement of CYP3A4 in human liver microsomes. Liu ZQ; Zhu B; Tan YF; Tan ZR; Wang LS; Huang SL; Shu Y; Zhou HH J Pharmacol Exp Ther; 2002 Jan; 300(1):105-11. PubMed ID: 11752104 [TBL] [Abstract][Full Text] [Related]
25. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes. Wen X; Wang JS; Neuvonen PJ; Backman JT Eur J Clin Pharmacol; 2002 Jan; 57(11):799-804. PubMed ID: 11868802 [TBL] [Abstract][Full Text] [Related]
26. CYP2C subfamily, primarily CYP2C9, catalyses the enantioselective demethylation of the endocrine disruptor pesticide methoxychlor in human liver microsomes: use of inhibitory monoclonal antibodies in P450 identification. Hu Y; Krausz K; Gelboin HV; Kupfer D Xenobiotica; 2004 Feb; 34(2):117-32. PubMed ID: 14985143 [TBL] [Abstract][Full Text] [Related]
27. Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine. Giancarlo GM; Venkatakrishnan K; Granda BW; von Moltke LL; Greenblatt DJ Eur J Clin Pharmacol; 2001 Apr; 57(1):31-6. PubMed ID: 11372587 [TBL] [Abstract][Full Text] [Related]
28. Human cytochrome P450 3A4-catalyzed testosterone 6 beta-hydroxylation and erythromycin N-demethylation. Competition during catalysis. Wang RW; Newton DJ; Scheri TD; Lu AY Drug Metab Dispos; 1997 Apr; 25(4):502-7. PubMed ID: 9107550 [TBL] [Abstract][Full Text] [Related]
29. Identification of human cytochrome P450 isoforms involved in the metabolism of S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid. Taguchi K; Konishi T; Nishikawa H; Kitamura S Xenobiotica; 1999 Sep; 29(9):899-907. PubMed ID: 10548450 [TBL] [Abstract][Full Text] [Related]
30. Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin. Yamazaki H; Shimada T Drug Metab Dispos; 1998 Nov; 26(11):1053-7. PubMed ID: 9806945 [TBL] [Abstract][Full Text] [Related]
31. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes. Karam WG; Goldstein JA; Lasker JM; Ghanayem BI Drug Metab Dispos; 1996 Oct; 24(10):1081-7. PubMed ID: 8894508 [TBL] [Abstract][Full Text] [Related]
32. Oxidation of cyclophosphamide to 4-hydroxycyclophosphamide and deschloroethylcyclophosphamide in human liver microsomes. Ren S; Yang JS; Kalhorn TF; Slattery JT Cancer Res; 1997 Oct; 57(19):4229-35. PubMed ID: 9331082 [TBL] [Abstract][Full Text] [Related]
33. Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4'-hydroxylation activities in livers of Japanese and Caucasian populations. Inoue K; Yamazaki H; Imiya K; Akasaka S; Guengerich FP; Shimada T Pharmacogenetics; 1997 Apr; 7(2):103-13. PubMed ID: 9170147 [TBL] [Abstract][Full Text] [Related]
34. Hydroxylation and demethylation of the tricyclic antidepressant nortriptyline by cDNA-expressed human cytochrome P-450 isozymes. Olesen OV; Linnet K Drug Metab Dispos; 1997 Jun; 25(6):740-4. PubMed ID: 9193876 [TBL] [Abstract][Full Text] [Related]
35. Identification of CYP3A4 as the principal enzyme catalyzing mifepristone (RU 486) oxidation in human liver microsomes. Jang GR; Wrighton SA; Benet LZ Biochem Pharmacol; 1996 Sep; 52(5):753-61. PubMed ID: 8765473 [TBL] [Abstract][Full Text] [Related]
36. Metabolism of tauromustine in liver and lung microsomes from various species. Tuvesson H; Gunnarsson PO; SeidegÄrd J Xenobiotica; 1999 Aug; 29(8):783-92. PubMed ID: 10553719 [TBL] [Abstract][Full Text] [Related]
37. Effects of 17beta-estradiol and testosterone on hepatic mRNA/protein levels and catalytic activities of CYP2M1, CYP2K1, and CYP3A27 in rainbow trout (Oncorhynchus mykiss). Buhler DR; Miranda CL; Henderson MC; Yang YH; Lee SJ; Wang-Buhler JL Toxicol Appl Pharmacol; 2000 Oct; 168(2):91-101. PubMed ID: 11032764 [TBL] [Abstract][Full Text] [Related]
38. Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil. Hyland R; Roe EG; Jones BC; Smith DA Br J Clin Pharmacol; 2001 Mar; 51(3):239-48. PubMed ID: 11298070 [TBL] [Abstract][Full Text] [Related]
39. Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. Miyazawa M; Shindo M; Shimada T Drug Metab Dispos; 2002 May; 30(5):602-7. PubMed ID: 11950794 [TBL] [Abstract][Full Text] [Related]
40. Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylation. McSorley LC; Daly AK Biochem Pharmacol; 2000 Aug; 60(4):517-26. PubMed ID: 10874126 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]